ImmunoCellular Therapeutics Ltd Company Profile (NYSEMKT:IMUC)

About ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)

ImmunoCellular Therapeutics Ltd logoImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is developing immune-based therapies for the treatment of cancers. The Company's cancer immunotherapies target cancer stem cells (CSCs), which are the drivers of tumor growth and disease recurrence. Its product candidate is ICT-107, which is in phase III testing. In addition, the Company also has a portfolio of other potential therapeutic immunotherapies using a range of approaches to treat cancer. Its other product candidates are ICT-140 and ICT-121. ICT-107 is a dendritic cell (DC) vaccine for the treatment of newly diagnosed glioblastoma multiforme (GBM), a type of brain cancer. ICT-140 is a DC vaccine that targets over seven tumor-associated antigens expressed on ovarian cancer cells. It is developing ICT-121, a dendritic cell (DC)-based vaccine targeting CD133+ CSCs for the treatment of recurrent GBM and other solid tumor cancers, including ovarian, pancreatic and breast cancers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Symbol: NYSEMKT:IMUC
  • CUSIP: 45253610
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $1.99
  • 200 Day Moving Avg: $2.49
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
 

Frequently Asked Questions for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)

What is ImmunoCellular Therapeutics Ltd's stock symbol?

ImmunoCellular Therapeutics Ltd trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "IMUC."

How were ImmunoCellular Therapeutics Ltd's earnings last quarter?

ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) posted its earnings results on Monday, August, 22nd. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. View ImmunoCellular Therapeutics Ltd's Earnings History.

Where is ImmunoCellular Therapeutics Ltd's stock going? Where will ImmunoCellular Therapeutics Ltd's stock price be in 2017?

1 analysts have issued twelve-month price targets for ImmunoCellular Therapeutics Ltd's stock. Their predictions range from $2.00 to $2.00. On average, they expect ImmunoCellular Therapeutics Ltd's share price to reach $2.00 in the next twelve months. View Analyst Ratings for ImmunoCellular Therapeutics Ltd.

Who are some of ImmunoCellular Therapeutics Ltd's key competitors?

How do I buy ImmunoCellular Therapeutics Ltd stock?

Shares of ImmunoCellular Therapeutics Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

Analyst Ratings

Consensus Ratings for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.00

Analysts' Ratings History for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Show:
DateFirmActionRatingPrice TargetDetails
11/11/2016Maxim GroupDowngradeBuy -> HoldView Rating Details
11/12/2015Roth CapitalReiterated RatingBuy$3.00View Rating Details
(Data available from 5/26/2015 forward)

Earnings

Earnings History for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Earnings by Quarter for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Earnings History by Quarter for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016Q316($0.04)($0.04)ViewN/AView Earnings Details
8/22/2016Q2($0.07)($0.06)ViewListenView Earnings Details
5/12/2016Q116($0.07)($0.06)ViewListenView Earnings Details
3/30/2016Q415($0.06)($0.05)ViewListenView Earnings Details
11/10/2015Q315($0.06)($0.04)ViewN/AView Earnings Details
8/6/2015Q215($0.05)($0.03)ViewN/AView Earnings Details
5/11/2015Q1($0.02)($0.02)ViewN/AView Earnings Details
3/9/2015Q414($0.05)($0.04)ViewN/AView Earnings Details
11/10/2014Q314($0.06)($0.03)ViewN/AView Earnings Details
8/11/2014($0.06)($0.04)ViewN/AView Earnings Details
5/9/2014Q114($0.04)($0.05)ViewN/AView Earnings Details
5/9/2013Q1 2013($0.08)($0.05)ViewN/AView Earnings Details
3/5/2013Q4 2012($0.08)$0.01ViewN/AView Earnings Details
11/12/2012Q312($0.02)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Insider Trades by Quarter for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Institutional Ownership by Quarter for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Insider Trades by Quarter for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/30/2015Andrew GengosCEOBuy10,000$0.44$4,400.00View SEC Filing  
2/18/2015Andrew GengosCEOBuy41,333$0.60$24,799.80View SEC Filing  
2/18/2015Andrew GengosCEOBuy41,333$0.60$24,799.80View SEC Filing  
2/18/2015Anthony GringeriVPBuy30,000$0.60$18,000.00View SEC Filing  
2/18/2015David FractorVPBuy16,667$0.60$10,000.20View SEC Filing  
8/21/2014Anthony GringeriVPBuy11,000$0.91$10,010.00View SEC Filing  
8/14/2014Andrew GengosCEOBuy10,000$0.90$9,000.00View SEC Filing  
12/20/2013Gary TitusDirectorBuy18,000$0.78$14,040.00View SEC Filing  
12/18/2013Andrew GengosCEOBuy27,000$0.72$19,440.00View SEC Filing  
10/21/2013John S YuInsiderSell267,387$2.91$778,096.17View SEC Filing  
8/29/2013James BenderVPSell14,203$2.87$40,762.61View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Latest Headlines for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Source:
DateHeadline
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 26 at 2:18 AM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 23 at 5:28 PM
finance.yahoo.com logoThe Law Offices of Howard G. Smith Notifies Investors of the Filing of a Securities Class Action on Behalf of ImmunoCellular Therapeutics, Ltd. Investors
finance.yahoo.com - May 23 at 11:16 AM
finance.yahoo.com logoIMUC INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving ImmunoCellular Therapeutics, Ltd. and a Lead Plaintiff Deadline of June 30, 2017
finance.yahoo.com - May 23 at 11:16 AM
globenewswire.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds ... - GlobeNewswire (press release)
globenewswire.com - May 22 at 5:24 PM
globenewswire.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ImmunoCellular ... - GlobeNewswire (press release)
globenewswire.com - May 20 at 10:45 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 20 at 9:48 AM
finance.yahoo.com logoEQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC
finance.yahoo.com - May 19 at 10:28 AM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 19 at 10:28 AM
finance.yahoo.com logoEQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 17 at 5:53 PM
finance.yahoo.com logoIMUC INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving ImmunoCellular Therapeutics, Ltd. and a Lead Plaintiff Deadline of June 30, 2017
finance.yahoo.com - May 17 at 9:58 AM
finance.yahoo.com logoEQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 16 at 5:48 PM
finance.yahoo.com logoBragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit has been Filed against ImmunoCellular Therapeutics, Ltd. (IMUC) and Encourages Investors to Contact the Firm
finance.yahoo.com - May 16 at 11:04 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC
finance.yahoo.com - May 16 at 11:04 AM
finance.yahoo.com logoImmunoCellular Therapeutics Announces First Quarter 2017 Financial Results
finance.yahoo.com - May 15 at 5:25 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 15 at 5:25 PM
globenewswire.com logoIMPORTANT IMMUNOCELLULAR THERAPEUTICS, LTD. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz ... - GlobeNewswire (press release)
globenewswire.com - May 14 at 8:15 AM
finance.yahoo.com logoINVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 13 at 9:26 AM
finance.yahoo.com logoIMPORTANT IMMUNOCELLULAR THERAPEUTICS, LTD. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against ImmunoCellular Therapeutics, Ltd.
finance.yahoo.com - May 12 at 6:35 PM
businesswire.com logoIMUC EQUITY ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving ImmunoCellular ... - Business Wire (press release)
www.businesswire.com - May 11 at 6:28 PM
finance.yahoo.com logoIMUC EQUITY ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving ImmunoCellular Therapeutics, Ltd. and a Lead Plaintiff Deadline of June 30, 2017
finance.yahoo.com - May 11 at 6:28 PM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 11 at 6:28 PM
businesswire.com logoIMUC LOSS NOTICE: Rosen Law Firm Reminds ImmunoCellular Therapeutics, Ltd. of Important Deadline in Class ... - Business Wire (press release)
www.businesswire.com - May 10 at 11:22 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 10 at 11:22 PM
prnewswire.com logoIMPORTANT EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against - PR Newswire (press release)
www.prnewswire.com - May 10 at 6:22 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC
finance.yahoo.com - May 10 at 6:22 PM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 10 at 6:22 PM
finance.yahoo.com logoIMUC LOSS NOTICE: Rosen Law Firm Reminds ImmunoCellular Therapeutics, Ltd. of Important Deadline in Class Action – IMUC
finance.yahoo.com - May 10 at 6:22 PM
businesswire.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action ... - Business Wire (press release)
www.businesswire.com - May 10 at 1:21 PM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 9 at 5:40 PM
finance.yahoo.com logoEQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC
finance.yahoo.com - May 9 at 12:26 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 – IMUC
finance.yahoo.com - May 8 at 5:33 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 8 at 5:33 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 8 at 5:32 PM
finance.yahoo.com logoThe Klein Law Firm Announces a Class Action Filed on Behalf of ImmunoCellular Therapeutics, Ltd. Shareholders and a Lead Plaintiff Deadline of June 30, 2017
finance.yahoo.com - May 5 at 5:54 PM
finance.yahoo.com logoSHAREHOLDER NOTICE: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd.
finance.yahoo.com - May 5 at 5:54 PM
globenewswire.com logoGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against ImmunoCellular Therapeutics ... - GlobeNewswire (press release)
globenewswire.com - May 4 at 11:05 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 4 at 11:05 PM
finance.yahoo.com logoGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against ImmunoCellular Therapeutics, Ltd. (IMUC)
finance.yahoo.com - May 4 at 11:05 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 4 at 11:05 PM
businesswire.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ImmunoCellular ... - Business Wire (press release)
www.businesswire.com - May 4 at 6:03 PM
globenewswire.com logoIMUC SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class ... - GlobeNewswire (press release)
globenewswire.com - May 4 at 6:03 PM
businesswire.com logoRobbins Arroyo LLP: ImmunoCellular Therapeutics, Ltd. (IMUC) Misled Shareholders According to a Recently Filed ... - Business Wire (press release)
www.businesswire.com - May 4 at 6:03 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 4 at 6:03 PM
finance.yahoo.com logoGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of ImmunoCellular Therapeutics, Ltd. Investors and Encourages Investors to Contact the Firm
finance.yahoo.com - May 4 at 6:03 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. – IMUC
finance.yahoo.com - May 4 at 1:00 AM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 4 at 1:00 AM
finance.yahoo.com logoIMUC SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving ImmunoCellular Therapeutics, Ltd. and a Lead Plaintiff Deadline of June 30, 2017
finance.yahoo.com - May 4 at 1:00 AM
finance.yahoo.com logoINVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd.
finance.yahoo.com - May 4 at 1:00 AM
finance.yahoo.com logoRobbins Arroyo LLP: ImmunoCellular Therapeutics, Ltd. (IMUC) Misled Shareholders According to a Recently Filed Class Action
finance.yahoo.com - May 4 at 1:00 AM

Social

This page was last updated on 5/26/2017 by MarketBeat.com Staff